VG081821AC Tablets for Early to Mid-stage Parkinson's Disease

NCT07725562 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease (PD)

Interventions

DRUG: VG081821AC
OTHER: Placebo

Sponsor

Zhejiang Vimgreen Pharmaceuticals, Ltd.